
Heart failure after myocardial infarction: incidence and predictors
Author(s) -
Jenča Dominik,
Melenovský Vojtěch,
Stehlik Josef,
Staněk Vladimír,
Kettner Jiří,
Kautzner Josef,
Adámková Věra,
Wohlfahrt Peter
Publication year - 2021
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.13144
Subject(s) - medicine , heart failure , myocardial infarction , cardiology , incidence (geometry) , epidemiology , guideline , intensive care medicine , pathology , physics , optics
Aims The aim of the present paper was to provide an up‐to‐date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction. Methods and results Based on literature review, several clinical risk factors and biochemical, genetic, and imaging biomarkers were identified to predict the risk of HF development after myocardial infarction. Conclusions Heart failure is still a frequent complication of myocardial infarction. Timely identification of subjects at risk for HF development using a multimodality approach, and early initiation of guideline‐directed HF therapy in these patients, can decrease the HF burden.